Literature DB >> 23117791

LAS: a software platform to support oncological data management.

Elena Baralis1, Andrea Bertotti, Alessandro Fiori, Alberto Grand.   

Abstract

The rapid technological evolution in the biomedical and molecular oncology fields is providing research laboratories with huge amounts of complex and heterogeneous data. Automated systems are needed to manage and analyze this knowledge, allowing the discovery of new information related to tumors and the improvement of medical treatments. This paper presents the Laboratory Assistant Suite (LAS), a software platform with a modular architecture designed to assist researchers throughout diverse laboratory activities. The LAS supports the management and the integration of heterogeneous biomedical data, and provides graphical tools to build complex analyses on integrated data. Furthermore, the LAS interfaces are designed to ease data collection and management even in hostile environments (e.g., in sterile conditions), so as to improve data quality.

Entities:  

Mesh:

Year:  2012        PMID: 23117791     DOI: 10.1007/s10916-012-9891-6

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  7 in total

1.  VISDA: an open-source caBIG analytical tool for data clustering and beyond.

Authors:  Jiajing Wang; Huai Li; Yitan Zhu; Malik Yousef; Michael Nebozhyn; Michael Showe; Louise Showe; Jianhua Xuan; Robert Clarke; Yue Wang
Journal:  Bioinformatics       Date:  2007-05-31       Impact factor: 6.937

Review 2.  Data management in structural genomics: an overview.

Authors:  Sabrina Haquin; Eric Oeuillet; Anne Pajon; Mark Harris; Alwyn T Jones; Herman van Tilbeurgh; John L Markley; Zolt Zolnai; Anne Poupon
Journal:  Methods Mol Biol       Date:  2008

3.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

Authors:  T R Golub; D K Slonim; P Tamayo; C Huard; M Gaasenbeek; J P Mesirov; H Coller; M L Loh; J R Downing; M A Caligiuri; C D Bloomfield; E S Lander
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

4.  The Cancer Biomedical Informatics Grid (caBIG): infrastructure and applications for a worldwide research community.

Authors: 
Journal:  Stud Health Technol Inform       Date:  2007

5.  A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

Authors:  Andrea Bertotti; Giorgia Migliardi; Francesco Galimi; Francesco Sassi; Davide Torti; Claudio Isella; Davide Corà; Federica Di Nicolantonio; Michela Buscarino; Consalvo Petti; Dario Ribero; Nadia Russolillo; Andrea Muratore; Paolo Massucco; Alberto Pisacane; Luca Molinaro; Emanuele Valtorta; Andrea Sartore-Bianchi; Mauro Risio; Lorenzo Capussotti; Marcello Gambacorta; Salvatore Siena; Enzo Medico; Anna Sapino; Silvia Marsoni; Paolo M Comoglio; Alberto Bardelli; Livio Trusolino
Journal:  Cancer Discov       Date:  2011-09-02       Impact factor: 39.397

6.  Screensaver: an open source lab information management system (LIMS) for high throughput screening facilities.

Authors:  Andrew N Tolopko; John P Sullivan; Sean D Erickson; David Wrobel; Su L Chiang; Katrina Rudnicki; Stewart Rudnicki; Jennifer Nale; Laura M Selfors; Dara Greenhouse; Jeremy L Muhlich; Caroline E Shamu
Journal:  BMC Bioinformatics       Date:  2010-05-18       Impact factor: 3.169

7.  MausDB: an open source application for phenotype data and mouse colony management in large-scale mouse phenotyping projects.

Authors:  Holger Maier; Christoph Lengger; Bruno Simic; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabé de Angelis
Journal:  BMC Bioinformatics       Date:  2008-03-26       Impact factor: 3.169

  7 in total
  11 in total

Review 1.  Interrogating open issues in cancer precision medicine with patient-derived xenografts.

Authors:  Annette T Byrne; Denis G Alférez; Frédéric Amant; Daniela Annibali; Joaquín Arribas; Andrew V Biankin; Alejandra Bruna; Eva Budinská; Carlos Caldas; David K Chang; Robert B Clarke; Hans Clevers; George Coukos; Virginie Dangles-Marie; S Gail Eckhardt; Eva Gonzalez-Suarez; Els Hermans; Manuel Hidalgo; Monika A Jarzabek; Steven de Jong; Jos Jonkers; Kristel Kemper; Luisa Lanfrancone; Gunhild Mari Mælandsmo; Elisabetta Marangoni; Jean-Christophe Marine; Enzo Medico; Jens Henrik Norum; Héctor G Palmer; Daniel S Peeper; Pier Giuseppe Pelicci; Alejandro Piris-Gimenez; Sergio Roman-Roman; Oscar M Rueda; Joan Seoane; Violeta Serra; Laura Soucek; Dominique Vanhecke; Alberto Villanueva; Emilie Vinolo; Andrea Bertotti; Livio Trusolino
Journal:  Nat Rev Cancer       Date:  2017-01-20       Impact factor: 60.716

2.  HER2 activating mutations are targets for colorectal cancer treatment.

Authors:  Shyam M Kavuri; Naveen Jain; Francesco Galimi; Francesca Cottino; Simonetta M Leto; Giorgia Migliardi; Adam C Searleman; Wei Shen; John Monsey; Livio Trusolino; Samuel A Jacobs; Andrea Bertotti; Ron Bose
Journal:  Cancer Discov       Date:  2015-08       Impact factor: 39.397

3.  One tool to find them all: a case of data integration and querying in a distributed LIMS platform.

Authors:  Alberto Grand; Emanuele Geda; Andrea Mignone; Andrea Bertotti; Alessandro Fiori
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

4.  Semalytics: a semantic analytics platform for the exploration of distributed and heterogeneous cancer data in translational research.

Authors:  Andrea Mignone; Alberto Grand; Alessandro Fiori; Enzo Medico; Andrea Bertotti
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

5.  PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.

Authors:  Concetta D'Ambrosio; Jessica Erriquez; Maddalena Arigoni; Sonia Capellero; Gloria Mittica; Eleonora Ghisoni; Fulvio Borella; Dionyssios Katsaros; Silvana Privitera; Marisa Ribotta; Elena Maldi; Giovanna Di Nardo; Enrico Berrino; Tiziana Venesio; Riccardo Ponzone; Marco Vaira; Douglas Hall; Mercedes Jimenez-Linan; Anna L Paterson; Raffaele A Calogero; James D Brenton; Giorgio Valabrega; Maria Flavia Di Renzo; Martina Olivero
Journal:  Cells       Date:  2020-02-14       Impact factor: 7.666

6.  Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition.

Authors:  Federica Verginelli; Alberto Pisacane; Gennaro Gambardella; Antonio D'Ambrosio; Ermes Candiello; Marco Ferrio; Mara Panero; Laura Casorzo; Silvia Benvenuti; Eliano Cascardi; Rebecca Senetta; Elena Geuna; Andrea Ballabio; Filippo Montemurro; Anna Sapino; Paolo M Comoglio; Carla Boccaccio
Journal:  Nat Commun       Date:  2021-05-03       Impact factor: 14.919

7.  The genomic landscape of response to EGFR blockade in colorectal cancer.

Authors:  Andrea Bertotti; Eniko Papp; Siân Jones; Vilmos Adleff; Valsamo Anagnostou; Barbara Lupo; Mark Sausen; Jillian Phallen; Carolyn A Hruban; Collin Tokheim; Noushin Niknafs; Monica Nesselbush; Karli Lytle; Francesco Sassi; Francesca Cottino; Giorgia Migliardi; Eugenia R Zanella; Dario Ribero; Nadia Russolillo; Alfredo Mellano; Andrea Muratore; Gianluca Paraluppi; Mauro Salizzoni; Silvia Marsoni; Michael Kragh; Johan Lantto; Andrea Cassingena; Qing Kay Li; Rachel Karchin; Robert Scharpf; Andrea Sartore-Bianchi; Salvatore Siena; Luis A Diaz; Livio Trusolino; Victor E Velculescu
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

8.  Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

Authors:  Jessica Erriquez; Martina Olivero; Gloria Mittica; Maria Stella Scalzo; Marco Vaira; Michele De Simone; Riccardo Ponzone; Dionyssios Katsaros; Massimo Aglietta; Raffaele Calogero; Maria Flavia Di Renzo; Giorgio Valabrega
Journal:  Oncotarget       Date:  2016-05-03

9.  MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.

Authors:  Francesca De Bacco; Antonio D'Ambrosio; Elena Casanova; Francesca Orzan; Roberta Neggia; Raffaella Albano; Federica Verginelli; Manuela Cominelli; Pietro L Poliani; Paolo Luraghi; Gigliola Reato; Serena Pellegatta; Gaetano Finocchiaro; Timothy Perera; Elisabetta Garibaldi; Pietro Gabriele; Paolo M Comoglio; Carla Boccaccio
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137

10.  Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.

Authors:  Claudio Isella; Francesco Brundu; Sara E Bellomo; Francesco Galimi; Eugenia Zanella; Roberta Porporato; Consalvo Petti; Alessandro Fiori; Francesca Orzan; Rebecca Senetta; Carla Boccaccio; Elisa Ficarra; Luigi Marchionni; Livio Trusolino; Enzo Medico; Andrea Bertotti
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.